椎体形成術と骨盤形成術の市場：製品別（椎体形成術、椎体形成術）、エンドユーザー別（病院、外来手術センター）：世界の機会分析および産業予測、2021-2031年

椎体形成術と骨盤形成術の世界市場は、2021年に7億5710万米ドルと評価され、2031年には13億810万米ドルに達し、2022年から2031年にかけてCAGRは5.6％で成長すると予測されています。

椎体形成術と骨盤形成術は低侵襲手術法で、脊髄の椎骨圧迫骨折の治療に使用されています。椎体形成術は、骨折した椎体に特殊なセメントを注入する技術で、脊髄の痛みを緩和し、身体の可動性を回復させるのに役立ちます。脊椎形成術では、ポリメチルメタクリレートと呼ばれる骨セメントを、中空の針を通して骨折した骨に注入します。一方、脊椎形成術も特殊なセメントを患者様の脊椎に注入しますが、さらに風船のような装置で治療のための空間を作るというステップを踏むため、バルーン形成術とも呼ばれます。また、がんで損傷した椎体などの脊椎骨折の治療にも、後頭骨形成術が推奨されています。これらの手術は、脊椎骨折による痛みを止め、骨を安定させ、圧迫骨折により失われた椎体の高さを回復させるために行われます。

椎体骨折の発生件数の増加が、市場成長の主な促進要因となっています。2021年11月に米国整形外科学会が発表したデータによると、米国では毎年150万件の椎体柱骨折が発生していると推定されており、この症状は主に骨粗鬆症や転倒、スポーツ外傷、交通事故などの外傷によって発生します。この症状は、治療や数ヶ月の装具着用で治りますが、重度の脊椎骨折の場合は、外科的処置が必要です。

さらに、椎体形成術や骨盤形成術は重度骨折の治療法です。椎体骨折の発生率の上昇は、さらに椎体形成術や骨盤形成術などの治療手順に対する要求を高め、したがって、市場の成長を推進しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

• 市場の定義と範囲
• 主な調査結果
  • 主な投資ポケット
• ポーターのファイブフォース分析
• 主要企業のポジショニング
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• COVID-19 影響分析

第4章 椎体形成術と骨盤形成術市場：製品別

• 概要
  • 市場規模および予測
• カイフォプラスティ
  • 主な市場動向、成長要因、機会
  • 市場規模・予測：地域別
  • 市場シェア分析：国別
• 椎体形成術
  • 主な市場動向、成長要因、機会
  • 市場規模・予測：地域別
  • 市場シェア分析：国別

第5章 椎体形成術と骨盤形成術市場：エンドユーザー別

• 概要
  • 市場規模・予測
• 病院
  • 主な市場動向、成長要因と機会
  • 市場規模・予測：地域別
  • 市場シェア分析：国別
• 外来手術センター
  • 主な市場動向、成長要因、機会
  • 市場規模・予測：地域別
  • 市場シェア分析：国別

第6章 椎体形成術と骨盤形成術市場：地域別

• 概要
  • 市場規模・予測
• 北米
  • 主な動向と機会
  • 北米市場規模・予測：製品別
  • 北米市場規模・予測：エンドユーザー別
  • 北米市場規模・予測：国別
    • 米国
    • カナダ
    • メキシコ
• 欧州
  • 主な動向と機会
  • 欧州市場規模・予測：製品別
  • 欧州市場規模・予測：エンドユーザー別
  • 欧州市場規模・予測：国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州地域
• アジア太平洋地域
  • 主な動向と機会
  • アジア太平洋地域の市場規模・予測：製品別
  • アジア太平洋地域の市場規模・予測：エンドユーザー別
  • アジア太平洋地域の市場規模・予測：国別
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
• LAMEA
  • 主な動向と機会
  • LAMEAの市場規模・予測：製品別
  • LAMEAの市場規模・予測：エンドユーザー別
  • LAMEAの市場規模・予測：国別
    • ブラジル
    • サウジアラビア
    • 南アフリカ共和国
    • LAMEAの残りの地域

第7章 企業情勢

• イントロダクション
• 主要成功戦略
• 主要10社の製品マッピング
• 競合ダッシュボード
• 競合ヒートマップ
• 主な発展

第8章 企業プロファイル

• Johnson and Johnson（DePuy Synthes）
• Medtronic plc
• Globus Medical Inc
• Halma plc
• Zavation LLC
• BPB MEDICA-BIOPSYBELL
• Merit Medical Systems Inc.
• Seawon Meditech
• Joimax GmbH
• Stryker Corporation

LIST OF TABLES

• TABLE 1. GLOBAL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 2. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR KYPHOPLASTY, BY REGION, 2021-2031 (REVENUE, $MILLION)
• TABLE 3. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR KYPHOPLASTY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
• TABLE 4. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR VERTEBROPLASTY, BY REGION, 2021-2031 (REVENUE, $MILLION)
• TABLE 5. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR VERTEBROPLASTY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
• TABLE 6. GLOBAL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 7. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
• TABLE 8. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
• TABLE 9. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
• TABLE 10. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
• TABLE 11. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
• TABLE 12. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 13. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 14. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
• TABLE 15. U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 16. U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 17. CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 18. CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 19. MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 20. MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 21. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 22. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 23. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
• TABLE 24. GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 25. GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 26. FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 27. FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 28. UK VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 29. UK VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 30. ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 31. ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 32. SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 33. SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 34. REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 35. REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 36. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 37. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 38. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
• TABLE 39. JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 40. JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 41. CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 42. CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 43. INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 44. INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 45. AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 46. AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 47. SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 48. SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 49. REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 50. REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 51. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 52. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 53. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
• TABLE 54. BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 55. BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 56. SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 57. SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 58. SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 59. SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 60. REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
• TABLE 61. REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
• TABLE 62.JOHNSON AND JOHNSON (DEPUY SYNTHES): COMPANY SNAPSHOT
• TABLE 63.JOHNSON AND JOHNSON (DEPUY SYNTHES): OPERATING SEGMENTS
• TABLE 64.JOHNSON AND JOHNSON (DEPUY SYNTHES): PRODUCT PORTFOLIO
• TABLE 65.JOHNSON AND JOHNSON (DEPUY SYNTHES): NET SALES
• TABLE 66.JOHNSON AND JOHNSON (DEPUY SYNTHES): KEY STRATERGIES
• TABLE 67.MEDTRONIC PLC: COMPANY SNAPSHOT
• TABLE 68.MEDTRONIC PLC: OPERATING SEGMENTS
• TABLE 69.MEDTRONIC PLC: PRODUCT PORTFOLIO
• TABLE 70.MEDTRONIC PLC: NET SALES
• TABLE 71.MEDTRONIC PLC: KEY STRATERGIES
• TABLE 72.GLOBUS MEDICAL INC: COMPANY SNAPSHOT
• TABLE 73.GLOBUS MEDICAL INC: OPERATING SEGMENTS
• TABLE 74.GLOBUS MEDICAL INC: PRODUCT PORTFOLIO
• TABLE 75.GLOBUS MEDICAL INC: NET SALES
• TABLE 76.GLOBUS MEDICAL INC: KEY STRATERGIES
• TABLE 77.HALMA PLC: COMPANY SNAPSHOT
• TABLE 78.HALMA PLC: OPERATING SEGMENTS
• TABLE 79.HALMA PLC: PRODUCT PORTFOLIO
• TABLE 80.HALMA PLC: NET SALES
• TABLE 81.HALMA PLC: KEY STRATERGIES
• TABLE 82.ZAVATION LLC: COMPANY SNAPSHOT
• TABLE 83.ZAVATION LLC: OPERATING SEGMENTS
• TABLE 84.ZAVATION LLC: PRODUCT PORTFOLIO
• TABLE 85.ZAVATION LLC: NET SALES
• TABLE 86.ZAVATION LLC: KEY STRATERGIES
• TABLE 87.BPB MEDICA - BIOPSYBELL: COMPANY SNAPSHOT
• TABLE 88.BPB MEDICA - BIOPSYBELL: OPERATING SEGMENTS
• TABLE 89.BPB MEDICA - BIOPSYBELL: PRODUCT PORTFOLIO
• TABLE 90.BPB MEDICA - BIOPSYBELL: NET SALES
• TABLE 91.BPB MEDICA - BIOPSYBELL: KEY STRATERGIES
• TABLE 92.MERIT MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT
• TABLE 93.MERIT MEDICAL SYSTEMS INC.: OPERATING SEGMENTS
• TABLE 94.MERIT MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO
• TABLE 95.MERIT MEDICAL SYSTEMS INC.: NET SALES
• TABLE 96.MERIT MEDICAL SYSTEMS INC.: KEY STRATERGIES
• TABLE 97.SEAWON MEDITECH: COMPANY SNAPSHOT
• TABLE 98.SEAWON MEDITECH: OPERATING SEGMENTS
• TABLE 99.SEAWON MEDITECH: PRODUCT PORTFOLIO
• TABLE 100.SEAWON MEDITECH: NET SALES
• TABLE 101.SEAWON MEDITECH: KEY STRATERGIES
• TABLE 102.JOIMAX GMBH: COMPANY SNAPSHOT
• TABLE 103.JOIMAX GMBH: OPERATING SEGMENTS
• TABLE 104.JOIMAX GMBH: PRODUCT PORTFOLIO
• TABLE 105.JOIMAX GMBH: NET SALES
• TABLE 106.JOIMAX GMBH: KEY STRATERGIES
• TABLE 107.STRYKER CORPORATION: COMPANY SNAPSHOT
• TABLE 108.STRYKER CORPORATION: OPERATING SEGMENTS
• TABLE 109.STRYKER CORPORATION: PRODUCT PORTFOLIO
• TABLE 110.STRYKER CORPORATION: NET SALES
• TABLE 111.STRYKER CORPORATION: KEY STRATERGIES

LIST OF FIGURES

• FIGURE 1.VERTEBROPLASTY AND KYPHOPLASTY MARKET SEGMENTATION
• FIGURE 2.VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031
• FIGURE 3.VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031
• FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
• FIGURE 5.PORTER FIVE-1
• FIGURE 6.PORTER FIVE-2
• FIGURE 7.PORTER FIVE-3
• FIGURE 8.PORTER FIVE-4
• FIGURE 9.PORTER FIVE-5
• FIGURE 10.TOP PLAYER POSITIONING
• FIGURE 11.VERTEBROPLASTY AND KYPHOPLASTY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
• FIGURE 12.VERTEBROPLASTY AND KYPHOPLASTY MARKET,BY PRODUCT,2021(%)
• FIGURE 13.COMPARATIVE SHARE ANALYSIS OF KYPHOPLASTY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
• FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VERTEBROPLASTY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
• FIGURE 15.VERTEBROPLASTY AND KYPHOPLASTY MARKET,BY END USER,2021(%)
• FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HOSPITALS VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
• FIGURE 17.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
• FIGURE 18.VERTEBROPLASTY AND KYPHOPLASTY MARKET BY REGION,2021
• FIGURE 19.U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 20.CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 21.MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 22.GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 23.FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 24.UK VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 25.ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 26.SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 27.REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 28.JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 29.CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 30.INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 31.AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 32.SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 33.REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 34.BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 35.SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 36.SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 37.REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
• FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
• FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
• FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
• FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 42.COMPETITIVE DASHBOARD
• FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
• FIGURE 44.JOHNSON AND JOHNSON (DEPUY SYNTHES).: NET SALES ($MILLION)
• FIGURE 45.MEDTRONIC PLC.: NET SALES ($MILLION)
• FIGURE 46.GLOBUS MEDICAL INC.: NET SALES ($MILLION)
• FIGURE 47.HALMA PLC.: NET SALES ($MILLION)
• FIGURE 48.ZAVATION LLC.: NET SALES ($MILLION)
• FIGURE 49.BPB MEDICA - BIOPSYBELL.: NET SALES ($MILLION)
• FIGURE 50.MERIT MEDICAL SYSTEMS INC..: NET SALES ($MILLION)
• FIGURE 51.SEAWON MEDITECH.: NET SALES ($MILLION)
• FIGURE 52.JOIMAX GMBH.: NET SALES ($MILLION)
• FIGURE 53.STRYKER CORPORATION.: NET SALES ($MILLION)

The global vertebroplasty and kyphoplasty market was valued at $757.1 million in 2021, and is projected to reach $1,308.1 million by 2031, registering a CAGR of 5.6% from 2022 to 2031.Vertebroplasty and kyphoplasty are minimally invasive surgical techniques, used for the treatment of vertebral compression factures in the spinal cord. Vertebroplasty is a technique, which includes the injection of special cement into the fractured vertebra that provides relief from spinal pain and helps restore the mobility of body. In vertebroplasty, bone cement, also named as polymethyl-methacrylate, is injected through the hollow needle into the fractured bone. On the other hand, kyphoplasty also involves the injection of special cement into the patients' vertebrae, but with an additional step by creating space for the treatment with a balloon-like device, which is also known as balloon kyphoplasty. In addition, kyphoplasty is recommended for the treatment of cancer-damaged vertebrae and other spinal fractures. These surgical procedures are used to stop the pain caused by a spinal fracture, to stabilize the bone and to restore the loss of vertebral body height due to the compression fracture.

Rise in number of vertebral column factures is the major driving factor for the growth of the market. According to the data published by American Academy of Orthopedic Surgeons in November 2021, there are an estimated 1.5 million vertebral column fracture cases each year in the U.S. This condition mainly occurs due to osteoporosis and traumas like falls, sports injuries or car accidents, and others. Although, the condition can be treated through therapies and by wearing braces for few months, but severe spinal fractures need to be treated through surgical procedure. Furthermore, vertebroplasty and kyphoplasty techniques are

severe fractures. Rise in incidence of vertebral column fractures further demands for treatment procedures such as vertebroplasty and kyphoplasty, thus, propelling the growth of the market.

In addition, rise in advancements in the healthcare sector is also driving the market growth. For instance, the development of OsseoFlex System, which includes an expandable titanium mesh cage, is used in the treatment of osteoporotic vertebral fractures (OVCFs). This technique is used to prevent kyphotic deformity by compacting the surrounding trabecular bone. Further, the height of the fractured vertebra is restored by injection of special cement and by the compaction of the trabecular bone by the titanium mesh cage. In addition, less cement is required in such technique than that of the percutaneous kyphoplasty. Thus, more such advancements in the field of vertebroplasty and kyphoplasty augment the growth of the market during the forecast period.

Also, rise in adoption of minimally invasive surgeries around the globe, is driving the market growth. As vertebroplasty and kyphoplasty are well-known minimally invasive surgery techniques, nowadays there is witnessed rise in their adoption for the treatment of vertebral compression fractures. The advantages offered by minimally invasive surgeries, such as less pain, faster recovery after an operation, earlier return to work, and better results are leading to rise in adoption of this technique by the healthcare provider and also the patients, which further leads to the expansion of the market.

Furthermore, factors such as increase in geriatric population, rise in incidence of vertebral fractures, growing healthcare facilities, increase in demand for technically advanced products, presence of major market manufacturers along with rising technological advancements in vertebroplasty and kyphoplasty, and increasing developments in the medical devices industry are driving the growth of the vertebroplasty and kyphoplasty market. Although many factors are diving the growth of the market, the high cost related to these advanced

surgical techniques along with minor risk associated with these surgeries is causing hindrance to the growth of the market. In addition, the major opportunities available for the vertebroplasty and kyphoplasty market include medical tourism due to high cost of surgeries, growth opportunity in emerging markets, and technological advancement in product associated with the management of vertebral fractures.

The vertebroplasty and kyphoplasty market is studied on the basis of product, end user, and region. By product, the market is segmented into kyphoplasty and vertebroplasty. By end user, it is classified into hospitals and ambulatory surgical centers. Region-wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include, BPB Medica - Biopsybell, Johnson & Johnson (DePuy Synthes), Globus Medical Inc., Halma plc. (IZI Medical Products), Joimax GmbH, Medtronic plc., Merit Medical Systems Inc., Seawon Meditech, Stryker Corporation, and Zavation.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vertebroplasty and kyphoplasty market analysis from 2021 to 2031 to identify the prevailing vertebroplasty and kyphoplasty market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the vertebroplasty and kyphoplasty market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global vertebroplasty and kyphoplasty market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

• Kyphoplasty
• Vertebroplasty

By End User

• Hospitals
• Ambulatory Surgical Centers

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • Johnson and Johnson (DePuy Synthes)
  • Medtronic plc
  • Globus Medical Inc
  • Halma plc
  • Zavation LLC
  • BPB MEDICA - BIOPSYBELL
  • Merit Medical Systems Inc.
  • Seawon Meditech
  • Joimax GmbH
  • Stryker Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Kyphoplasty
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market share analysis by country
• 4.3 Vertebroplasty
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market share analysis by country

CHAPTER 5: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Hospitals
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market share analysis by country
• 5.3 Ambulatory Surgical Centers
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market share analysis by country

CHAPTER 6: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 North America
  • 6.2.1 Key trends and opportunities
  • 6.2.2 North America Market size and forecast, by Product
  • 6.2.3 North America Market size and forecast, by End User
  • 6.2.4 North America Market size and forecast, by country
    • 6.2.4.1 U.S.
    • 6.2.4.1.1 Key market trends, growth factors and opportunities
    • 6.2.4.1.2 Market size and forecast, by Product
    • 6.2.4.1.3 Market size and forecast, by End User
    • 6.2.4.2 Canada
    • 6.2.4.2.1 Key market trends, growth factors and opportunities
    • 6.2.4.2.2 Market size and forecast, by Product
    • 6.2.4.2.3 Market size and forecast, by End User
    • 6.2.4.3 Mexico
    • 6.2.4.3.1 Key market trends, growth factors and opportunities
    • 6.2.4.3.2 Market size and forecast, by Product
    • 6.2.4.3.3 Market size and forecast, by End User
• 6.3 Europe
  • 6.3.1 Key trends and opportunities
  • 6.3.2 Europe Market size and forecast, by Product
  • 6.3.3 Europe Market size and forecast, by End User
  • 6.3.4 Europe Market size and forecast, by country
    • 6.3.4.1 Germany
    • 6.3.4.1.1 Key market trends, growth factors and opportunities
    • 6.3.4.1.2 Market size and forecast, by Product
    • 6.3.4.1.3 Market size and forecast, by End User
    • 6.3.4.2 France
    • 6.3.4.2.1 Key market trends, growth factors and opportunities
    • 6.3.4.2.2 Market size and forecast, by Product
    • 6.3.4.2.3 Market size and forecast, by End User
    • 6.3.4.3 UK
    • 6.3.4.3.1 Key market trends, growth factors and opportunities
    • 6.3.4.3.2 Market size and forecast, by Product
    • 6.3.4.3.3 Market size and forecast, by End User
    • 6.3.4.4 Italy
    • 6.3.4.4.1 Key market trends, growth factors and opportunities
    • 6.3.4.4.2 Market size and forecast, by Product
    • 6.3.4.4.3 Market size and forecast, by End User
    • 6.3.4.5 Spain
    • 6.3.4.5.1 Key market trends, growth factors and opportunities
    • 6.3.4.5.2 Market size and forecast, by Product
    • 6.3.4.5.3 Market size and forecast, by End User
    • 6.3.4.6 Rest of Europe
    • 6.3.4.6.1 Key market trends, growth factors and opportunities
    • 6.3.4.6.2 Market size and forecast, by Product
    • 6.3.4.6.3 Market size and forecast, by End User
• 6.4 Asia-Pacific
  • 6.4.1 Key trends and opportunities
  • 6.4.2 Asia-Pacific Market size and forecast, by Product
  • 6.4.3 Asia-Pacific Market size and forecast, by End User
  • 6.4.4 Asia-Pacific Market size and forecast, by country
    • 6.4.4.1 Japan
    • 6.4.4.1.1 Key market trends, growth factors and opportunities
    • 6.4.4.1.2 Market size and forecast, by Product
    • 6.4.4.1.3 Market size and forecast, by End User
    • 6.4.4.2 China
    • 6.4.4.2.1 Key market trends, growth factors and opportunities
    • 6.4.4.2.2 Market size and forecast, by Product
    • 6.4.4.2.3 Market size and forecast, by End User
    • 6.4.4.3 India
    • 6.4.4.3.1 Key market trends, growth factors and opportunities
    • 6.4.4.3.2 Market size and forecast, by Product
    • 6.4.4.3.3 Market size and forecast, by End User
    • 6.4.4.4 Australia
    • 6.4.4.4.1 Key market trends, growth factors and opportunities
    • 6.4.4.4.2 Market size and forecast, by Product
    • 6.4.4.4.3 Market size and forecast, by End User
    • 6.4.4.5 South Korea
    • 6.4.4.5.1 Key market trends, growth factors and opportunities
    • 6.4.4.5.2 Market size and forecast, by Product
    • 6.4.4.5.3 Market size and forecast, by End User
    • 6.4.4.6 Rest of Asia-Pacific
    • 6.4.4.6.1 Key market trends, growth factors and opportunities
    • 6.4.4.6.2 Market size and forecast, by Product
    • 6.4.4.6.3 Market size and forecast, by End User
• 6.5 LAMEA
  • 6.5.1 Key trends and opportunities
  • 6.5.2 LAMEA Market size and forecast, by Product
  • 6.5.3 LAMEA Market size and forecast, by End User
  • 6.5.4 LAMEA Market size and forecast, by country
    • 6.5.4.1 Brazil
    • 6.5.4.1.1 Key market trends, growth factors and opportunities
    • 6.5.4.1.2 Market size and forecast, by Product
    • 6.5.4.1.3 Market size and forecast, by End User
    • 6.5.4.2 Saudi Arabia
    • 6.5.4.2.1 Key market trends, growth factors and opportunities
    • 6.5.4.2.2 Market size and forecast, by Product
    • 6.5.4.2.3 Market size and forecast, by End User
    • 6.5.4.3 South Africa
    • 6.5.4.3.1 Key market trends, growth factors and opportunities
    • 6.5.4.3.2 Market size and forecast, by Product
    • 6.5.4.3.3 Market size and forecast, by End User
    • 6.5.4.4 Rest of LAMEA
    • 6.5.4.4.1 Key market trends, growth factors and opportunities
    • 6.5.4.4.2 Market size and forecast, by Product
    • 6.5.4.4.3 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

• 7.1. Introduction
• 7.2. Top winning strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

• 8.1 Johnson and Johnson (DePuy Synthes)
  • 8.1.1 Company overview
  • 8.1.2 Company snapshot
  • 8.1.3 Operating business segments
  • 8.1.4 Product portfolio
  • 8.1.5 Business performance
  • 8.1.6 Key strategic moves and developments
• 8.2 Medtronic plc
  • 8.2.1 Company overview
  • 8.2.2 Company snapshot
  • 8.2.3 Operating business segments
  • 8.2.4 Product portfolio
  • 8.2.5 Business performance
  • 8.2.6 Key strategic moves and developments
• 8.3 Globus Medical Inc
  • 8.3.1 Company overview
  • 8.3.2 Company snapshot
  • 8.3.3 Operating business segments
  • 8.3.4 Product portfolio
  • 8.3.5 Business performance
  • 8.3.6 Key strategic moves and developments
• 8.4 Halma plc
  • 8.4.1 Company overview
  • 8.4.2 Company snapshot
  • 8.4.3 Operating business segments
  • 8.4.4 Product portfolio
  • 8.4.5 Business performance
  • 8.4.6 Key strategic moves and developments
• 8.5 Zavation LLC
  • 8.5.1 Company overview
  • 8.5.2 Company snapshot
  • 8.5.3 Operating business segments
  • 8.5.4 Product portfolio
  • 8.5.5 Business performance
  • 8.5.6 Key strategic moves and developments
• 8.6 BPB MEDICA - BIOPSYBELL
  • 8.6.1 Company overview
  • 8.6.2 Company snapshot
  • 8.6.3 Operating business segments
  • 8.6.4 Product portfolio
  • 8.6.5 Business performance
  • 8.6.6 Key strategic moves and developments
• 8.7 Merit Medical Systems Inc.
  • 8.7.1 Company overview
  • 8.7.2 Company snapshot
  • 8.7.3 Operating business segments
  • 8.7.4 Product portfolio
  • 8.7.5 Business performance
  • 8.7.6 Key strategic moves and developments
• 8.8 Seawon Meditech
  • 8.8.1 Company overview
  • 8.8.2 Company snapshot
  • 8.8.3 Operating business segments
  • 8.8.4 Product portfolio
  • 8.8.5 Business performance
  • 8.8.6 Key strategic moves and developments
• 8.9 Joimax GmbH
  • 8.9.1 Company overview
  • 8.9.2 Company snapshot
  • 8.9.3 Operating business segments
  • 8.9.4 Product portfolio
  • 8.9.5 Business performance
  • 8.9.6 Key strategic moves and developments
• 8.10 Stryker Corporation
  • 8.10.1 Company overview
  • 8.10.2 Company snapshot
  • 8.10.3 Operating business segments
  • 8.10.4 Product portfolio
  • 8.10.5 Business performance
  • 8.10.6 Key strategic moves and developments